Riverstone Holdings Ltd
SGX:AP4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Riverstone Holdings Ltd
SGX:AP4
|
SG |
|
B
|
BioMarin Pharmaceutical Inc
F:BM8
|
US |
Wall St Price Targets
AP4 Price Targets Summary
Riverstone Holdings Ltd
According to Wall Street analysts, the average 1-year price target for AP4 is 1 SGD with a low forecast of 0.91 SGD and a high forecast of 1.27 SGD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AP4's stock price target?
Price Target
1
SGD
According to Wall Street analysts, the average 1-year price target for AP4 is 1 SGD with a low forecast of 0.91 SGD and a high forecast of 1.27 SGD.
What is the Revenue forecast for Riverstone Holdings Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Riverstone Holdings Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Riverstone Holdings Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Riverstone Holdings Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Riverstone Holdings Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 8%.